Johnson & Johnson subsidiary pays $18 million to U.S. in settlement
Saturday, July 23, 2016 - 15:31
in Mathematics & Economics
Sarah MuléWASHINGTON, July 23 (UPI) -- Johnson & Johnson's subsidiary, Acclarent, will pay $18 million to resolve allegations that the company marketed a medical device for use without FDA approval.